Targeted therapies for bone sarcomas

Yazar: Heymann, Dominique, Rédini, Françoise
Baskı/Yayın Bilgisi 2013

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

Yazar: Redini, Françoise, Heymann, Dominique
Yayımlandı Front Oncol (2015)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

Yazar: Verrecchia, Franck, Rédini, Françoise
Yayımlandı Front Oncol (2018)

RANKL/RANK/OPG: key therapeutic target in bone oncology

Yazar: Ando, Kosei, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2008

TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment

Yazar: Picarda, Gaëlle, Trichet, Valérie, Téletchéa, Stéphane, Heymann, Dominique, Rédini, Françoise
Baskı/Yayın Bilgisi 2011

Mifamurtide for the treatment of nonmetastatic osteosarcoma

Yazar: Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2011

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression

Yazar: Lézot, Frédéric, Corre, Isabelle, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Yayımlandı Cells (2020)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

Yazar: Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Yayımlandı Cells (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors

Yazar: Talbot, Julie, Dupuy, Maryne, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Yayımlandı Biomolecules (2020)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

Yazar: Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Yayımlandı Int J Mol Sci (2019)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

Yazar: Morice, Sarah, Danieau, Geoffroy, Rédini, Françoise, Brounais-Le-Royer, Bénédicte, Verrecchia, Franck
Yayımlandı Cancers (Basel) (2020)

Molecular Alterations Associated with Osteosarcoma Development

Yazar: Ando, Kosei, Mori, Kanji, Verrecchia, Franck, Marc, Baud'huin, Rédini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2012

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

Yazar: Ando, Kosei, Heymann, Marie-Françoise, Stresing, Verena, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2013

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

Yazar: Lamora, Audrey, Mullard, Mathilde, Amiaud, Jérôme, Brion, Régis, Heymann, Dominique, Redini, Françoise, Verrecchia, Franck
Yayımlandı Oncotarget (2015)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression

Yazar: Lamora, Audrey, Talbot, Julie, Mullard, Mathilde, Brounais-Le Royer, Benedicte, Redini, Françoise, Verrecchia, Franck
Yayımlandı J Clin Med (2016)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

Yazar: Le Goff, Benoit, Soltner, Elise, Charrier, Céline, Maugars, Yves, Rédini, Françoise, Heymann, Dominique, Berthelot, Jean-Marie
Baskı/Yayın Bilgisi 2009

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

Yazar: Gobin, Bérengère, Moriceau, Gatien, Ory, Benjamin, Charrier, Céline, Brion, Régis, Blanchard, Frederic, Redini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2014

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer

Yazar: Biteau, Kevin, Guiho, Romain, Chatelais, Mathias, Taurelle, Julien, Chesneau, Julie, Corradini, Nadège, Heymann, Dominique, Redini, Françoise
Yayımlandı Am J Cancer Res (2016)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

Yazar: Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Baskı/Yayın Bilgisi 2014

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

Yazar: Grimaud, Eva, Soubigou, Luc, Couillaud, Séverine, Coipeau, Patrick, Moreau, Anne, Passuti, Norbert, Gouin, François, Redini, Françoise, Heymann, Dominique
Baskı/Yayın Bilgisi 2003